| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | C-C motif chemokine 2|HC11|Monocyte chemoattractant protein 1|Monocyte chemotactic and activating factor|MCAF|Monocyte chemotactic protein 1|MCP-1|Monocyte secretory protein JE|Small-inducible cytokine A2|CCL2|MCP1|SCYA2 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human MCP-1 (Monocyte Chemotactic Protein 1) is a molecular target commonly studied in immunology, signal transduction, and neuroscience research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of MCP-1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of MCP-1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
MCP-1 (Monocyte Chemotactic Protein 1) may also be referenced as C-C motif chemokine 2, HC11, and Monocyte chemoattractant protein 1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how MCP-1 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, signal transduction, and neuroscience research.
- Interpreting shifts in MCP-1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
MCP-1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, signal transduction, and neuroscience studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Biomarkers of oxidation, inflammation and intestinal permeability in persons with diabetes mellitus with parenteral nutrition: A multicenter randomized trial
IF: 7.4 Journal: Clinical Nutrition Author: Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA)-BIONAND Platform, Málaga, Spain. Cited Date: 2025-10-17
Differences in HDL Remodeling during Healthy Pregnancy and Pregnancy with Cardiometabolic Complications
IF: 6 Journal: Antioxidants Author: Gynecology and Obstetrics Clinic Narodni Front, 11000 Belgrade, Serbia Cited Date: 2024-08-09
SERPINA3: A novel inflammatory biomarker associated with cerebral small vessel disease burden in ischemic stroke
IF: 5.5 Journal: CNS Neuroscience & Therapeutics Author: Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China Cited Date: 2023-09-28
Association of sympathovagal imbalance with increased inflammation and impaired adaptive immunity in bladder cancer patients
IF: 4.9 Journal: International Journal of Molecular Sciences Author: Institute of Immunology, Faculty of Medicine, Comenius University in Bratislava, Odborarske namestie 14, 811 08 Bratislava, Slovakia. Cited Date: 2025-10-17
Association of HLA-G Expression, Its Genetic Variants and Related Neuro-Immunomodulation with Characteristics of Bladder Carcinoma
IF: 4.5 Journal: Cancers Author: Institute of Immunology, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia. Cited Date: 2024-11-29
Thiostrepton suppresses intrahepatic cholangiocarcinoma progression via FOXM1-mediated tumor-associated macrophages reprogramming
IF: 4.5 Journal: Translational Oncology Author: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, PR China. Cited Date: 2025-03-14